A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

Publisher： Karger

E-ISSN： 1421-9832|205|4|389-393

ISSN： 1018-8665

Source： Dermatology, Vol.205, Iss.4, 2002-12, pp. : 389-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness of Once-Daily Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol in the Treatment of Psoriasis vulgaris

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Efficacy of Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol for the Treatment of Psoriasis vulgaris: A Randomised, Double-Blind Trial

By  

Dermatology, Vol. 209, Iss. 4, 2004-12 ,pp. : 308-313

Karger

Access to resources Recommend Favorite

Calcipotriol plus Betamethasone Dipropionate Scalp Formulation Is Effective and Well Tolerated in the Treatment of Scalp Psoriasis: A Phase II Study

By  

Dermatology, Vol. 217, Iss. 2, 2008-05 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Treatment of Psoriasis with a New Combination of Calcipotriol and Betamethasone Dipropionate: A Flow Cytometric Study

By  

Dermatology, Vol. 203, Iss. 2, 2001-09 ,pp. : 148-152

Karger

Access to resources Recommend Favorite